HUVIS CORPORATION

As of June 30, 2026, HUVIS CORPORATION carries a market capitalization of 58.91B, placing it among publicly traded companies globally. Its enterprise value stands at 381.66B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

As of June 30, 2026, HUVIS CORPORATION has 32.91M shares outstanding.

These figures are as of June 30, 2026. The price-to-sales ratio is 0.07, and the price-to-book ratio stands at 0.23.

As of June 30, 2026, HUVIS CORPORATION trades at an EV/EBITDA multiple of 9.54 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 0.43 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 26.39 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. These enterprise value multiples are built on an enterprise value of 381.66B versus a market cap of 58.91B, with the gap driven by net debt and cash on the balance sheet.

As of June 30, 2026, HUVIS CORPORATION maintains a current ratio of 0.94, meaning it holds 0.9x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 136.41, indicating elevated leverage, while an interest coverage ratio of 2.49 demonstrates limited ability to service its debt obligations.

Over the twelve months ended June 30, 2026, HUVIS CORPORATION posted a negative return on equity (ROE) of -5.00, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -1.60, reflecting losses generated across the asset base. The company generates approximately 1.26B in revenue per employee across its workforce of 707.75, a quick read on workforce productivity versus industry peers. Inventory turnover of 5.52 indicates how many times HUVIS CORPORATION sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended June 30, 2026, HUVIS CORPORATION recorded an income tax benefit of -1.96B rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -14.35B and -12.39B in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

As of the close on October 23, 2026, HUVIS CORPORATION's stock has declined approximately 37.29% over the past 52 weeks. The 50-day moving average sits at 1,951.48, while the 200-day moving average is 2,390.16.

Over the twelve months ended June 30, 2026, HUVIS CORPORATION generated 889.65B in revenue and converted that into -12.39B in net income, yielding earnings per share of -375.57. EBITDA reached 40.00B, while operating income came in at 14.46B.

As of June 30, 2026, HUVIS CORPORATION holds 19.70B in cash and equivalents against 342.45B in total debt, resulting in a net debt position of 321.07B. Total book value stands at 251.05B, with working capital of -23.01B providing operational flexibility.

HUVIS CORPORATION produced 12.76B in operating cash flow over the twelve months ended June 30, 2026. After subtracting -14.29B in capital expenditures, free cash flow totaled -1.53B - equivalent to -46.36 per share.

Over the twelve months ended June 30, 2026, HUVIS CORPORATION posted a gross margin of 7.80, reflecting its pricing power and cost economics. The operating margin of 1.63 and net profit margin of -1.39 provide insight into operational efficiency.

These figures cover the twelve months ended June 30, 2026. Free cash flow yield is negative at -2.59: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -35.55, meaning HUVIS CORPORATION raised more capital through share issuance and new debt than it returned via dividends and buybacks.

As of June 30, 2026, HUVIS CORPORATION has an Altman Z-Score of 1.08, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.